[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2018-2023 Global Insulin Drug and Delivery Technologies Consumption Market Report

June 2018 | 136 pages | ID: 24675515EC3EN
LP Information

US$ 4,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Insulin Drug and Delivery Technologies market for 2018-2023.

Insulin is a protein hormone that is used as a medication to treat high blood glucose. This includes in diabetes mellitus type 1, diabetes mellitus type 2, gestational diabetes, and complications of  diabetes such as  diabetic ketoacidosis and hyperosmolar hyperglycemic states. It is also used along with glucose to treat high blood potassium levels. Typically it is given by injection under the skin, but some forms may also be used by injection into a vein or muscle.
The emerging technologies in the insulin drug and delivery field have potential in the diabetes market, with improved glucose control, along with improved and well-accepted newer delivery methods. Modern industries and research institutes have begun to explore newer method for diabetes control in adults and juveniles, leading to a steady market for these technologies. Research and development (R&D) spending, increasing competition, patent expiries and emerging technologies are guiding this to a new direction. The new advancements, new product launches, and increased awareness and early detection of the disease have influenced the market to grow in the foreseeable future. 

Over the next five years, LPI(LP Information) projects that Insulin Drug and Delivery Technologies will register a 9.2% CAGR in terms of revenue, reach US$ 55900 million by 2023, from US$ 36000 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Insulin Drug and Delivery Technologies market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:
  • Insulin Syringes
  • Insulin Vials
  • Insulin Pens
  • Insulin Pumps
Segmentation by application:
  • Diabetes Mellitus Type 1
  • Diabetes Mellitus Type 2
  • Gestational Diabetes
This report also splits the market by region:
  • Americas
  • United States
  • Canada
  • Mexico
  • Brazil
  • APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Spain
  • Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
  • Sanofi
  • Eli Lilly and Company
  • Biocon
  • Julphar
  • Ypsomed
  • Becton, Dickinson and Company
  • ...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
  • To study and analyze the global Insulin Drug and Delivery Technologies consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
  • To understand the structure of Insulin Drug and Delivery Technologies market by identifying its various subsegments.
  • Focuses on the key global Insulin Drug and Delivery Technologies manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  • To analyze the Insulin Drug and Delivery Technologies with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • To project the consumption of Insulin Drug and Delivery Technologies submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Insulin Drug and Delivery Technologies Consumption 2013-2023
  2.1.2 Insulin Drug and Delivery Technologies Consumption CAGR by Region
2.2 Insulin Drug and Delivery Technologies Segment by Type
  2.2.1 Insulin Syringes
  2.2.2 Insulin Vials
  2.2.3 Insulin Pens
  2.2.4 Insulin Pumps
2.3 Insulin Drug and Delivery Technologies Consumption by Type
  2.3.1 Global Insulin Drug and Delivery Technologies Consumption Market Share by Type (2013-2018)
  2.3.2 Global Insulin Drug and Delivery Technologies Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Insulin Drug and Delivery Technologies Sale Price by Type (2013-2018)
2.4 Insulin Drug and Delivery Technologies Segment by Application
  2.4.1 Diabetes Mellitus Type
  2.4.2 Diabetes Mellitus Type
  2.4.3 Gestational Diabetes
2.5 Insulin Drug and Delivery Technologies Consumption by Application
  2.5.1 Global Insulin Drug and Delivery Technologies Consumption Market Share by Application (2013-2018)
  2.5.2 Global Insulin Drug and Delivery Technologies Value and Market Share by Application (2013-2018)
  2.5.3 Global Insulin Drug and Delivery Technologies Sale Price by Application (2013-2018)

3 GLOBAL INSULIN DRUG AND DELIVERY TECHNOLOGIES BY PLAYERS

3.1 Global Insulin Drug and Delivery Technologies Sales Market Share by Players
  3.1.1 Global Insulin Drug and Delivery Technologies Sales by Players (2016-2018)
  3.1.2 Global Insulin Drug and Delivery Technologies Sales Market Share by Players (2016-2018)
3.2 Global Insulin Drug and Delivery Technologies Revenue Market Share by Players
  3.2.1 Global Insulin Drug and Delivery Technologies Revenue by Players (2016-2018)
  3.2.2 Global Insulin Drug and Delivery Technologies Revenue Market Share by Players (2016-2018)
3.3 Global Insulin Drug and Delivery Technologies Sale Price by Players
3.4 Global Insulin Drug and Delivery Technologies Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Insulin Drug and Delivery Technologies Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Insulin Drug and Delivery Technologies Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 INSULIN DRUG AND DELIVERY TECHNOLOGIES BY REGIONS

4.1 Insulin Drug and Delivery Technologies by Regions
  4.1.1 Global Insulin Drug and Delivery Technologies Consumption by Regions
  4.1.2 Global Insulin Drug and Delivery Technologies Value by Regions
4.2 Americas Insulin Drug and Delivery Technologies Consumption Growth
4.3 APAC Insulin Drug and Delivery Technologies Consumption Growth
4.4 Europe Insulin Drug and Delivery Technologies Consumption Growth
4.5 Middle East & Africa Insulin Drug and Delivery Technologies Consumption Growth

5 AMERICAS

5.1 Americas Insulin Drug and Delivery Technologies Consumption by Countries
  5.1.1 Americas Insulin Drug and Delivery Technologies Consumption by Countries (2013-2018)
  5.1.2 Americas Insulin Drug and Delivery Technologies Value by Countries (2013-2018)
5.2 Americas Insulin Drug and Delivery Technologies Consumption by Type
5.3 Americas Insulin Drug and Delivery Technologies Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Insulin Drug and Delivery Technologies Consumption by Countries
  6.1.1 APAC Insulin Drug and Delivery Technologies Consumption by Countries (2013-2018)
  6.1.2 APAC Insulin Drug and Delivery Technologies Value by Countries (2013-2018)
6.2 APAC Insulin Drug and Delivery Technologies Consumption by Type
6.3 APAC Insulin Drug and Delivery Technologies Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Insulin Drug and Delivery Technologies by Countries
  7.1.1 Europe Insulin Drug and Delivery Technologies Consumption by Countries (2013-2018)
  7.1.2 Europe Insulin Drug and Delivery Technologies Value by Countries (2013-2018)
7.2 Europe Insulin Drug and Delivery Technologies Consumption by Type
7.3 Europe Insulin Drug and Delivery Technologies Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Insulin Drug and Delivery Technologies by Countries
  8.1.1 Middle East & Africa Insulin Drug and Delivery Technologies Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Insulin Drug and Delivery Technologies Value by Countries (2013-2018)
8.2 Middle East & Africa Insulin Drug and Delivery Technologies Consumption by Type
8.3 Middle East & Africa Insulin Drug and Delivery Technologies Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Insulin Drug and Delivery Technologies Distributors
10.3 Insulin Drug and Delivery Technologies Customer

11 GLOBAL INSULIN DRUG AND DELIVERY TECHNOLOGIES MARKET FORECAST

11.1 Global Insulin Drug and Delivery Technologies Consumption Forecast (2018-2023)
11.2 Global Insulin Drug and Delivery Technologies Forecast by Regions
  11.2.1 Global Insulin Drug and Delivery Technologies Forecast by Regions (2018-2023)
  11.2.2 Global Insulin Drug and Delivery Technologies Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Insulin Drug and Delivery Technologies Forecast by Type
11.8 Global Insulin Drug and Delivery Technologies Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Sanofi
  12.1.1 Company Details
  12.1.2 Insulin Drug and Delivery Technologies Product Offered
  12.1.3 Sanofi Insulin Drug and Delivery Technologies Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Sanofi News
12.2 Eli Lilly and Company
  12.2.1 Company Details
  12.2.2 Insulin Drug and Delivery Technologies Product Offered
  12.2.3 Eli Lilly and Company Insulin Drug and Delivery Technologies Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Eli Lilly and Company News
12.3 Biocon
  12.3.1 Company Details
  12.3.2 Insulin Drug and Delivery Technologies Product Offered
  12.3.3 Biocon Insulin Drug and Delivery Technologies Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Biocon News
12.4 Julphar
  12.4.1 Company Details
  12.4.2 Insulin Drug and Delivery Technologies Product Offered
  12.4.3 Julphar Insulin Drug and Delivery Technologies Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Julphar News
12.5 Ypsomed
  12.5.1 Company Details
  12.5.2 Insulin Drug and Delivery Technologies Product Offered
  12.5.3 Ypsomed Insulin Drug and Delivery Technologies Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Ypsomed News
12.6 Becton, Dickinson and Company
  12.6.1 Company Details
  12.6.2 Insulin Drug and Delivery Technologies Product Offered
  12.6.3 Becton, Dickinson and Company Insulin Drug and Delivery Technologies Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Becton, Dickinson and Company News

...

13 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES AND FIGURES

Figure Picture of Insulin Drug and Delivery Technologies
Table Product Specifications of Insulin Drug and Delivery Technologies
Figure Insulin Drug and Delivery Technologies Report Years Considered
Figure Market Research Methodology
Figure Global Insulin Drug and Delivery Technologies Consumption Growth Rate 2013-2023 (K MT)
Figure Global Insulin Drug and Delivery Technologies Value Growth Rate 2013-2023 ($ Millions)
Table Insulin Drug and Delivery Technologies Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Insulin Syringes
Table Major Players of Insulin Syringes
Figure Product Picture of Insulin Vials
Table Major Players of Insulin Vials
Figure Product Picture of Insulin Pens
Table Major Players of Insulin Pens
Figure Product Picture of Insulin Pumps
Table Major Players of Insulin Pumps
Table Global Consumption Sales by Type (2013-2018)
Table Global Insulin Drug and Delivery Technologies Consumption Market Share by Type (2013-2018)
Figure Global Insulin Drug and Delivery Technologies Consumption Market Share by Type (2013-2018)
Table Global Insulin Drug and Delivery Technologies Revenue by Type (2013-2018) ($ million)
Table Global Insulin Drug and Delivery Technologies Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Insulin Drug and Delivery Technologies Value Market Share by Type (2013-2018)
Table Global Insulin Drug and Delivery Technologies Sale Price by Type (2013-2018)
Figure Insulin Drug and Delivery Technologies Consumed in Diabetes Mellitus Type
Figure Global Insulin Drug and Delivery Technologies Market: Diabetes Mellitus Type 1 (2013-2018) (K MT)
Figure Global Insulin Drug and Delivery Technologies Market: Diabetes Mellitus Type 1 (2013-2018) ($ Millions)
Figure Global Diabetes Mellitus Type 1 YoY Growth ($ Millions)
Figure Insulin Drug and Delivery Technologies Consumed in Diabetes Mellitus Type
Figure Global Insulin Drug and Delivery Technologies Market: Diabetes Mellitus Type 2 (2013-2018) (K MT)
Figure Global Insulin Drug and Delivery Technologies Market: Diabetes Mellitus Type 2 (2013-2018) ($ Millions)
Figure Global Diabetes Mellitus Type 2 YoY Growth ($ Millions)
Figure Insulin Drug and Delivery Technologies Consumed in Gestational Diabetes
Figure Global Insulin Drug and Delivery Technologies Market: Gestational Diabetes (2013-2018) (K MT)
Figure Global Insulin Drug and Delivery Technologies Market: Gestational Diabetes (2013-2018) ($ Millions)
Figure Global Gestational Diabetes YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Insulin Drug and Delivery Technologies Consumption Market Share by Application (2013-2018)
Figure Global Insulin Drug and Delivery Technologies Consumption Market Share by Application (2013-2018)
Table Global Insulin Drug and Delivery Technologies Value by Application (2013-2018)
Table Global Insulin Drug and Delivery Technologies Value Market Share by Application (2013-2018)
Figure Global Insulin Drug and Delivery Technologies Value Market Share by Application (2013-2018)
Table Global Insulin Drug and Delivery Technologies Sale Price by Application (2013-2018)
Table Global Insulin Drug and Delivery Technologies Sales by Players (2016-2018) (K MT)
Table Global Insulin Drug and Delivery Technologies Sales Market Share by Players (2016-2018)
Figure Global Insulin Drug and Delivery Technologies Sales Market Share by Players in 2016
Figure Global Insulin Drug and Delivery Technologies Sales Market Share by Players in 2017
Table Global Insulin Drug and Delivery Technologies Revenue by Players (2016-2018) ($ Millions)
Table Global Insulin Drug and Delivery Technologies Revenue Market Share by Players (2016-2018)
Figure Global Insulin Drug and Delivery Technologies Revenue Market Share by Players in 2016
Figure Global Insulin Drug and Delivery Technologies Revenue Market Share by Players in 2017
Table Global Insulin Drug and Delivery Technologies Sale Price by Players (2016-2018)
Figure Global Insulin Drug and Delivery Technologies Sale Price by Players in 2017
Table Global Insulin Drug and Delivery Technologies Manufacturing Base Distribution and Sales Area by Players
Table Players Insulin Drug and Delivery Technologies Products Offered
Table Insulin Drug and Delivery Technologies Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Insulin Drug and Delivery Technologies Consumption by Regions 2013-2018 (K MT)
Table Global Insulin Drug and Delivery Technologies Consumption Market Share by Regions 2013-2018
Figure Global Insulin Drug and Delivery Technologies Consumption Market Share by Regions 2013-2018
Table Global Insulin Drug and Delivery Technologies Value by Regions 2013-2018 ($ Millions)
Table Global Insulin Drug and Delivery Technologies Value Market Share by Regions 2013-2018
Figure Global Insulin Drug and Delivery Technologies Value Market Share by Regions 2013-2018
Figure Americas Insulin Drug and Delivery Technologies Consumption 2013-2018 (K MT)
Figure Americas Insulin Drug and Delivery Technologies Value 2013-2018 ($ Millions)
Figure APAC Insulin Drug and Delivery Technologies Consumption 2013-2018 (K MT)
Figure APAC Insulin Drug and Delivery Technologies Value 2013-2018 ($ Millions)
Figure Europe Insulin Drug and Delivery Technologies Consumption 2013-2018 (K MT)
Figure Europe Insulin Drug and Delivery Technologies Value 2013-2018 ($ Millions)
Figure Middle East & Africa Insulin Drug and Delivery Technologies Consumption 2013-2018 (K MT)
Figure Middle East & Africa Insulin Drug and Delivery Technologies Value 2013-2018 ($ Millions)
Table Americas Insulin Drug and Delivery Technologies Consumption by Countries (2013-2018) (K MT)
Table Americas Insulin Drug and Delivery Technologies Consumption Market Share by Countries (2013-2018)
Figure Americas Insulin Drug and Delivery Technologies Consumption Market Share by Countries in 2017
Table Americas Insulin Drug and Delivery Technologies Value by Countries (2013-2018) ($ Millions)
Table Americas Insulin Drug and Delivery Technologies Value Market Share by Countries (2013-2018)
Figure Americas Insulin Drug and Delivery Technologies Value Market Share by Countries in 2017
Table Americas Insulin Drug and Delivery Technologies Consumption by Type (2013-2018) (K MT)
Table Americas Insulin Drug and Delivery Technologies Consumption Market Share by Type (2013-2018)
Figure Americas Insulin Drug and Delivery Technologies Consumption Market Share by Type in 2017
Table Americas Insulin Drug and Delivery Technologies Consumption by Application (2013-2018) (K MT)
Table Americas Insulin Drug and Delivery Technologies Consumption Market Share by Application (2013-2018)
Figure Americas Insulin Drug and Delivery Technologies Consumption Market Share by Application in 2017
Figure United States Insulin Drug and Delivery Technologies Consumption Growth 2013-2018 (K MT)
Figure United States Insulin Drug and Delivery Technologies Value Growth 2013-2018 ($ Millions)
Figure Canada Insulin Drug and Delivery Technologies Consumption Growth 2013-2018 (K MT)
Figure Canada Insulin Drug and Delivery Technologies Value Growth 2013-2018 ($ Millions)
Figure Mexico Insulin Drug and Delivery Technologies Consumption Growth 2013-2018 (K MT)
Figure Mexico Insulin Drug and Delivery Technologies Value Growth 2013-2018 ($ Millions)
Table APAC Insulin Drug and Delivery Technologies Consumption by Countries (2013-2018) (K MT)
Table APAC Insulin Drug and Delivery Technologies Consumption Market Share by Countries (2013-2018)
Figure APAC Insulin Drug and Delivery Technologies Consumption Market Share by Countries in 2017
Table APAC Insulin Drug and Delivery Technologies Value by Countries (2013-2018) ($ Millions)
Table APAC Insulin Drug and Delivery Technologies Value Market Share by Countries (2013-2018)
Figure APAC Insulin Drug and Delivery Technologies Value Market Share by Countries in 2017
Table APAC Insulin Drug and Delivery Technologies Consumption by Type (2013-2018) (K MT)
Table APAC Insulin Drug and Delivery Technologies Consumption Market Share by Type (2013-2018)
Figure APAC Insulin Drug and Delivery Technologies Consumption Market Share by Type in 2017
Table APAC Insulin Drug and Delivery Technologies Consumption by Application (2013-2018) (K MT)
Table APAC Insulin Drug and Delivery Technologies Consumption Market Share by Application (2013-2018)
Figure APAC Insulin Drug and Delivery Technologies Consumption Market Share by Application in 2017
Figure China Insulin Drug and Delivery Technologies Consumption Growth 2013-2018 (K MT)
Figure China Insulin Drug and Delivery Technologies Value Growth 2013-2018 ($ Millions)
Figure Japan Insulin Drug and Delivery Technologies Consumption Growth 2013-2018 (K MT)
Figure Japan Insulin Drug and Delivery Technologies Value Growth 2013-2018 ($ Millions)
Figure Korea Insulin Drug and Delivery Technologies Consumption Growth 2013-2018 (K MT)
Figure Korea Insulin Drug and Delivery Technologies Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Insulin Drug and Delivery Technologies Consumption Growth 2013-2018 (K MT)
Figure Southeast Asia Insulin Drug and Delivery Technologies Value Growth 2013-2018 ($ Millions)
Figure India Insulin Drug and Delivery Technologies Consumption Growth 2013-2018 (K MT)
Figure India Insulin Drug and Delivery Technologies Value Growth 2013-2018 ($ Millions)
Figure Australia Insulin Drug and Delivery Technologies Consumption Growth 2013-2018 (K MT)
Figure Australia Insulin Drug and Delivery Technologies Value Growth 2013-2018 ($ Millions)
Table Europe Insulin Drug and Delivery Technologies Consumption by Countries (2013-2018) (K MT)
Table Europe Insulin Drug and Delivery Technologies Consumption Market Share by Countries (2013-2018)
Figure Europe Insulin Drug and Delivery Technologies Consumption Market Share by Countries in 2017
Table Europe Insulin Drug and Delivery Technologies Value by Countries (2013-2018) ($ Millions)
Table Europe Insulin Drug and Delivery Technologies Value Market Share by Countries (2013-2018)
Figure Europe Insulin Drug and Delivery Technologies Value Market Share by Countries in 2017
Table Europe Insulin Drug and Delivery Technologies Consumption by Type (2013-2018) (K MT)
Table Europe Insulin Drug and Delivery Technologies Consumption Market Share by Type (2013-2018)
Figure Europe Insulin Drug and Delivery Technologies Consumption Market Share by Type in 2017
Table Europe Insulin Drug and Delivery Technologies Consumption by Application (2013-2018) (K MT)
Table Europe Insulin Drug and Delivery Technologies Consumption Market Share by Application (2013-2018)
Figure Europe Insulin Drug and Delivery Technologies Consumption Market Share by Application in 2017
Figure Germany Insulin Drug and Delivery Technologies Consumption Growth 2013-2018 (K MT)
Figure Germany Insulin Drug and Delivery Technologies Value Growth 2013-2018 ($ Millions)
Figure France Insulin Drug and Delivery Technologies Consumption Growth 2013-2018 (K MT)
Figure France Insulin Drug and Delivery Technologies Value Growth 2013-2018 ($ Millions)
Figure UK Insulin Drug and Delivery Technologies Consumption Growth 2013-2018 (K MT)
Figure UK Insulin Drug and Delivery Technologies Value Growth 2013-2018 ($ Millions)
Figure Italy Insulin Drug and Delivery Technologies Consumption Growth 2013-2018 (K MT)
Figure Italy Insulin Drug and Delivery Technologies Value Growth 2013-2018 ($ Millions)
Figure Russia Insulin Drug and Delivery Technologies Consumption Growth 2013-2018 (K MT)
Figure Russia Insulin Drug and Delivery Technologies Value Growth 2013-2018 ($ Millions)
Figure Spain Insulin Drug and Delivery Technologies Consumption Growth 2013-2018 (K MT)
Figure Spain Insulin Drug and Delivery Technologies Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Insulin Drug and Delivery Technologies Consumption by Countries (2013-2018) (K MT)
Table Middle East & Africa Insulin Drug and Delivery Technologies Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Insulin Drug and Delivery Technologies Consumption Market Share by Countries in 2017
Table Middle East & Africa Insulin Drug and Delivery Technologies Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Insulin Drug and Delivery Technologies Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Insulin Drug and Delivery Technologies Value Market Share by Countries in 2017
Table Middle East & Africa Insulin Drug and Delivery Technologies Consumption by Type (2013-2018) (K MT)
Table Middle East & Africa Insulin Drug and Delivery Technologies Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Insulin Drug and Delivery Technologies Consumption Market Share by Type in 2017
Table Middle East & Africa Insulin Drug and Delivery Technologies Consumption by Application (2013-2018) (K MT)
Table Middle East & Africa Insulin Drug and Delivery Technologies Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Insulin Drug and Delivery Technologies Consumption Market Share by Application in 2017
Figure Egypt Insulin Drug and Delivery Technologies Consumption Growth 2013-2018 (K MT)
Figure Egypt Insulin Drug and Delivery Technologies Value Growth 2013-2018 ($ Millions)
Figure South Africa Insulin Drug and Delivery Technologies Consumption Growth 2013-2018 (K MT)
Figure South Africa Insulin Drug and Delivery Technologies Value Growth 2013-2018 ($ Millions)
Figure Israel Insulin Drug and Delivery Technologies Consumption Growth 2013-2018 (K MT)
Figure Israel Insulin Drug and Delivery Technologies Value Growth 2013-2018 ($ Millions)
Figure Turkey Insulin Drug and Delivery Technologies Consumption Growth 2013-2018 (K MT)
Figure Turkey Insulin Drug and Delivery Technologies Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Insulin Drug and Delivery Technologies Consumption Growth 2013-2018 (K MT)
Figure GCC Countries Insulin Drug and Delivery Technologies Value Growth 2013-2018 ($ Millions)
Table Insulin Drug and Delivery Technologies Distributors List
Table Insulin Drug and Delivery Technologies Customer List
Figure Global Insulin Drug and Delivery Technologies Consumption Growth Rate Forecast (2018-2023) (K MT)
Figure Global Insulin Drug and Delivery Technologies Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Insulin Drug and Delivery Technologies Consumption Forecast by Countries (2018-2023) (K MT)
Table Global Insulin Drug and Delivery Technologies Consumption Market Forecast by Regions
Table Global Insulin Drug and Delivery Technologies Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Insulin Drug and Delivery Technologies Value Market Share Forecast by Regions
Figure Americas Insulin Drug and Delivery Technologies Consumption 2018-2023 (K MT)
Figure Americas Insulin Drug and Delivery Technologies Value 2018-2023 ($ Millions)
Figure APAC Insulin Drug and Delivery Technologies Consumption 2018-2023 (K MT)
Figure APAC Insulin Drug and Delivery Technologies Value 2018-2023 ($ Millions)
Figure Europe Insulin Drug and Delivery Technologies Consumption 2018-2023 (K MT)
Figure Europe Insulin Drug and Delivery Technologies Value 2018-2023 ($ Millions)
Figure Middle East & Africa Insulin Drug and Delivery Technologies Consumption 2018-2023 (K MT)
Figure Middle East & Africa Insulin Drug and Delivery Technologies Value 2018-2023 ($ Millions)
Figure United States Insulin Drug and Delivery Technologies Consumption 2018-2023 (K MT)
Figure United States Insulin Drug and Delivery Technologies Value 2018-2023 ($ Millions)
Figure Canada Insulin Drug and Delivery Technologies Consumption 2018-2023 (K MT)
Figure Canada Insulin Drug and Delivery Technologies Value 2018-2023 ($ Millions)
Figure Mexico Insulin Drug and Delivery Technologies Consumption 2018-2023 (K MT)
Figure Mexico Insulin Drug and Delivery Technologies Value 2018-2023 ($ Millions)
Figure Brazil Insulin Drug and Delivery Technologies Consumption 2018-2023 (K MT)
Figure Brazil Insulin Drug and Delivery Technologies Value 2018-2023 ($ Millions)
Figure China Insulin Drug and Delivery Technologies Consumption 2018-2023 (K MT)
Figure China Insulin Drug and Delivery Technologies Value 2018-2023 ($ Millions)
Figure Japan Insulin Drug and Delivery Technologies Consumption 2018-2023 (K MT)
Figure Japan Insulin Drug and Delivery Technologies Value 2018-2023 ($ Millions)
Figure Korea Insulin Drug and Delivery Technologies Consumption 2018-2023 (K MT)
Figure Korea Insulin Drug and Delivery Technologies Value 2018-2023 ($ Millions)
Figure Southeast Asia Insulin Drug and Delivery Technologies Consumption 2018-2023 (K MT)
Figure Southeast Asia Insulin Drug and Delivery Technologies Value 2018-2023 ($ Millions)
Figure India Insulin Drug and Delivery Technologies Consumption 2018-2023 (K MT)
Figure India Insulin Drug and Delivery Technologies Value 2018-2023 ($ Millions)
Figure Australia Insulin Drug and Delivery Technologies Consumption 2018-2023 (K MT)
Figure Australia Insulin Drug and Delivery Technologies Value 2018-2023 ($ Millions)
Figure Germany Insulin Drug and Delivery Technologies Consumption 2018-2023 (K MT)
Figure Germany Insulin Drug and Delivery Technologies Value 2018-2023 ($ Millions)
Figure France Insulin Drug and Delivery Technologies Consumption 2018-2023 (K MT)
Figure France Insulin Drug and Delivery Technologies Value 2018-2023 ($ Millions)
Figure UK Insulin Drug and Delivery Technologies Consumption 2018-2023 (K MT)
Figure UK Insulin Drug and Delivery Technologies Value 2018-2023 ($ Millions)
Figure Italy Insulin Drug and Delivery Technologies Consumption 2018-2023 (K MT)
Figure Italy Insulin Drug and Delivery Technologies Value 2018-2023 ($ Millions)
Figure Russia Insulin Drug and Delivery Technologies Consumption 2018-2023 (K MT)
Figure Russia Insulin Drug and Delivery Technologies Value 2018-2023 ($ Millions)
Figure Spain Insulin Drug and Delivery Technologies Consumption 2018-2023 (K MT)
Figure Spain Insulin Drug and Delivery Technologies Value 2018-2023 ($ Millions)
Figure Egypt Insulin Drug and Delivery Technologies Consumption 2018-2023 (K MT)
Figure Egypt Insulin Drug and Delivery Technologies Value 2018-2023 ($ Millions)
Figure South Africa Insulin Drug and Delivery Technologies Consumption 2018-2023 (K MT)
Figure South Africa Insulin Drug and Delivery Technologies Value 2018-2023 ($ Millions)
Figure Israel Insulin Drug and Delivery Technologies Consumption 2018-2023 (K MT)
Figure Israel Insulin Drug and Delivery Technologies Value 2018-2023 ($ Millions)
Figure Turkey Insulin Drug and Delivery Technologies Consumption 2018-2023 (K MT)
Figure Turkey Insulin Drug and Delivery Technologies Value 2018-2023 ($ Millions)
Figure GCC Countries Insulin Drug and Delivery Technologies Consumption 2018-2023 (K MT)
Figure GCC Countries Insulin Drug and Delivery Technologies Value 2018-2023 ($ Millions)
Table Global Insulin Drug and Delivery Technologies Consumption Forecast by Type (2018-2023) (K MT)
Table Global Insulin Drug and Delivery Technologies Consumption Market Share Forecast by Type (2018-2023)
Table Global Insulin Drug and Delivery Technologies Value Forecast by Type (2018-2023) ($ Millions)
Table Global Insulin Drug and Delivery Technologies Value Market Share Forecast by Type (2018-2023)
Table Global Insulin Drug and Delivery Technologies Consumption Forecast by Application (2018-2023) (K MT)
Table Global Insulin Drug and Delivery Technologies Consumption Market Share Forecast by Application (2018-2023)
Table Global Insulin Drug and Delivery Technologies Value Forecast by Application (2018-2023) ($ Millions)
Table Global Insulin Drug and Delivery Technologies Value Market Share Forecast by Application (2018-2023)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Insulin Drug and Delivery Technologies Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sanofi Insulin Drug and Delivery Technologies Market Share (2016-2018)
Table Eli Lilly and Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly and Company Insulin Drug and Delivery Technologies Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Eli Lilly and Company Insulin Drug and Delivery Technologies Market Share (2016-2018)
Table Biocon Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biocon Insulin Drug and Delivery Technologies Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Biocon Insulin Drug and Delivery Technologies Market Share (2016-2018)
Table Julphar Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Julphar Insulin Drug and Delivery Technologies Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Julphar Insulin Drug and Delivery Technologies Market Share (2016-2018)
Table Ypsomed Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ypsomed Insulin Drug and Delivery Technologies Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Ypsomed Insulin Drug and Delivery Technologies Market Share (2016-2018)
Table Becton, Dickinson and Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Becton, Dickinson and Company Insulin Drug and Delivery Technologies Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Becton, Dickinson and Company Insulin Drug and Delivery Technologies Market Share (2016-2018)


More Publications